Table of Contents

August 2014, Volume 21, Number 4

Profile

    • Shuk-Mei Ho

    Battle against the odds: win with effort, attitude, and perseverance!

    Endocr Relat Cancer 21 (4) P19-P24, doi:10.1530/ERC-14-0272 first published on 13 June 2014

Editorial

    • Frank Claessens and
    • Wayne Tilley

    Androgen signalling and steroid receptor crosstalk in endocrine cancers

    Endocr Relat Cancer 21 (4) E3-E5, doi:10.1530/ERC-14-0274

Thematic Reviews

    • Stefan J Barfeld,
    • Harri M Itkonen,
    • Alfonso Urbanucci,
    • and Ian G Mills

    Androgen-regulated metabolism and biosynthesis in prostate cancer

    Endocr Relat Cancer 21 (4) T57-T66, doi:10.1530/ERC-13-0515 first published on 4 February 2014
    • Trevor M Penning

    Androgen biosynthesis in castration-resistant prostate cancer

    Endocr Relat Cancer 21 (4) T67-T78, doi:10.1530/ERC-14-0109 first published on 14 May 2014
    • Vijay K Gonugunta,
    • Lu Miao,
    • Gangadhara R Sareddy,
    • Preethi Ravindranathan,
    • Ratna Vadlamudi,
    • and Ganesh V Raj

    The social network of PELP1 and its implications in breast and prostate cancers

    Endocr Relat Cancer 21 (4) T79-T86, doi:10.1530/ERC-13-0502 first published on 23 May 2014
    • Kathryn E Ware,
    • Mariano A Garcia-Blanco,
    • Andrew J Armstrong,
    • and Scott M Dehm

    Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer

    Endocr Relat Cancer 21 (4) T87-T103, doi:10.1530/ERC-13-0470 first published on 23 May 2014
    • Christine Helsen,
    • Thomas Van den Broeck,
    • Arnout Voet,
    • Stefan Prekovic,
    • Hendrik Van Poppel,
    • Steven Joniau,
    • and Frank Claessens

    Androgen receptor antagonists for prostate cancer therapy

    Endocr Relat Cancer 21 (4) T105-T118, doi:10.1530/ERC-13-0545 first published on 17 March 2014
    • Carolyn A Allan,
    • Veronica R Collins,
    • Mark Frydenberg,
    • Robert I McLachlan,
    • and Kati L Matthiesson

    Androgen deprivation therapy complications

    Endocr Relat Cancer 21 (4) T119-T129, doi:10.1530/ERC-13-0467 first published on 28 May 2014
    • Yulia Koryakina,
    • Huy Q Ta,
    • and Daniel Gioeli

    Androgen receptor phosphorylation: biological context and functional consequences

    Endocr Relat Cancer 21 (4) T131-T145, doi:10.1530/ERC-13-0472 first published on 14 January 2014
    • Cera M Nieto,
    • Leah C Rider,
    • and Scott D Cramer

    Influence of stromal–epithelial interactions on androgen action

    Endocr Relat Cancer 21 (4) T147-T160, doi:10.1530/ERC-14-0138 first published on 28 May 2014
    • Keely M McNamara,
    • Nicole L Moore,
    • Theresa E Hickey,
    • Hironobu Sasano,
    • and Wayne D Tilley

    Complexities of androgen receptor signalling in breast cancer

    Endocr Relat Cancer 21 (4) T161-T181, doi:10.1530/ERC-14-0243 first published on 20 June 2014
    • Gerard A Tarulli,
    • Lisa M Butler,
    • Wayne D Tilley,
    • and Theresa E Hickey

    Bringing androgens up a NOTCH in breast cancer

    Endocr Relat Cancer 21 (4) T183-T202, doi:10.1530/ERC-14-0248 first published on 7 July 2014
    • Douglas A Gibson,
    • Ioannis Simitsidellis,
    • Frances Collins,
    • and Philippa T K Saunders

    Evidence of androgen action in endometrial and ovarian cancers

    Endocr Relat Cancer 21 (4) T203-T218, doi:10.1530/ERC-13-0551 first published on 12 March 2014
    • Adam W Nelson,
    • Wayne D Tilley,
    • David E Neal,
    • and Jason S Carroll

    Estrogen receptor beta in prostate cancer: friend or foe?

    Endocr Relat Cancer 21 (4) T219-T234, doi:10.1530/ERC-13-0508 first published on 8 January 2014

Commentary

    • Adrian F Daly and
    • Albert Beckers

    A bittersweet symphony

    Endocr Relat Cancer 21 (4) C7-C9, doi:10.1530/ERC-14-0296 first published on 25 June 2014

Reviews

    • Fernand Labrie

    GnRH agonists and the rapidly increasing use of combined androgen blockade in prostate cancer

    Endocr Relat Cancer 21 (4) R301-R317, doi:10.1530/ERC-13-0165 first published on 13 May 2014
    • Sandra Rodríguez-Rodero,
    • Elías Delgado-Álvarez,
    • Agustín F Fernández,
    • Juan L Fernández-Morera,
    • Edelmiro Menéndez-Torre,
    • and Mario F Fraga

    Epigenetic alterations in endocrine-related cancer

    Endocr Relat Cancer 21 (4) R319-R330, doi:10.1530/ERC-13-0070 first published on 4 June 2014
    • Eric Monsalves,
    • Kyle Juraschka,
    • Toru Tateno,
    • Sameer Agnihotri,
    • Sylvia L Asa,
    • Shereen Ezzat,
    • and Gelareh Zadeh

    The PI3K/AKT/mTOR pathway in the pathophysiology and treatment of pituitary adenomas

    Endocr Relat Cancer 21 (4) R331-R344, doi:10.1530/ERC-14-0188

Research

    • Myriem Boufraqech,
    • Lisa Zhang,
    • Meenu Jain,
    • Dhaval Patel,
    • Ryan Ellis,
    • Yin Xiong,
    • Mei He,
    • Naris Nilubol,
    • Maria J Merino,
    • and Electron Kebebew

    miR-145 suppresses thyroid cancer growth and metastasis and targets AKT3

    Endocr Relat Cancer 21 (4) 517-531, doi:10.1530/ERC-14-0077 first published on 29 April 2014
    • Xin Qiu,
    • Jung-Chien Cheng,
    • Hsun-Ming Chang,
    • and Peter C K Leung

    COX2 and PGE2 mediate EGF-induced E-cadherin-independent human ovarian cancer cell invasion

    Endocr Relat Cancer 21 (4) 533-543, doi:10.1530/ERC-13-0450
    • Hatem A Azim, Jr,
    • Sylvain Brohée,
    • Fedro A Peccatori,
    • Christine Desmedt,
    • Sherene Loi,
    • Diether Lambrechts,
    • Patrizia Dell'Orto,
    • Samira Majjaj,
    • Vinu Jose,
    • Nicole Rotmensz,
    • Michail Ignatiadis,
    • Giancarlo Pruneri,
    • Martine Piccart,
    • Giuseppe Viale,
    • and Christos Sotiriou

    Biology of breast cancer during pregnancy using genomic profiling

    Endocr Relat Cancer 21 (4) 545-554, doi:10.1530/ERC-14-0111 first published on 13 May 2014
    • Yi-Lin Chang,
    • Yu-Kan Hsu,
    • Tsung-Fan Wu,
    • Chieh-Ming Huang,
    • Li-Yin Liou,
    • Ya-Wen Chiu,
    • Yu-Hsuan Hsiao,
    • Fuh-Jinn Luo,
    • and Ta-Chun Yuan

    Regulation of estrogen receptor α function in oral squamous cell carcinoma cells by FAK signaling

    Endocr Relat Cancer 21 (4) 555-565, doi:10.1530/ERC-14-0102 first published on 13 May 2014
    • Florian Haller,
    • Evgeny A Moskalev,
    • Fabio R Faucz,
    • Sarah Barthelmeß,
    • Stefan Wiemann,
    • Matthias Bieg,
    • Guillaume Assie,
    • Jerome Bertherat,
    • Inga-Marie Schaefer,
    • Claudia Otto,
    • Eleanor Rattenberry,
    • Eamonn R Maher,
    • Philipp Ströbel,
    • Martin Werner,
    • J Aidan Carney,
    • Arndt Hartmann,
    • Constantine A Stratakis,
    • and Abbas Agaimy

    Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad

    Endocr Relat Cancer 21 (4) 567-577, doi:10.1530/ERC-14-0254 first published on 23 May 2014
    • Yu Wang,
    • Andres Roma,
    • Rosalie Nolley,
    • Fadi Abdul-Karim,
    • Donna M Peehl,
    • and Charis Eng

    Nuclear KLLN expression associates with improved relapse-free survival for prostate carcinoma

    Endocr Relat Cancer 21 (4) 579-586, doi:10.1530/ERC-14-0148
    • María Ángeles Castilla,
    • María Ángeles López-García,
    • María Reina Atienza,
    • Juan Manuel Rosa-Rosa,
    • Juan Díaz-Martín,
    • María Luisa Pecero,
    • Begoña Vieites,
    • Laura Romero-Pérez,
    • Javier Benítez,
    • Annarica Calcabrini,
    • and José Palacios

    VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer

    Endocr Relat Cancer 21 (4) 587-599, doi:10.1530/ERC-13-0485 first published on 2 June 2014
    • Maria Cristina De Martino,
    • Richard A Feelders,
    • Wouter W de Herder,
    • Peter M van Koetsveld,
    • Fadime Dogan,
    • Joseph A M J L Janssen,
    • A Marlijn Waaijers,
    • Claudia Pivonello,
    • Steven W J Lamberts,
    • Annamaria Colao,
    • Ronald R de Krijger,
    • Rosario Pivonello,
    • and Leo J Hofland

    Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors

    Endocr Relat Cancer 21 (4) 601-613, doi:10.1530/ERC-13-0112 first published on 2 June 2014
    • Irvin M Modlin,
    • Ignat Drozdov,
    • Daniele Alaimo,
    • Stephen Callahan,
    • Nancy Teixiera,
    • Lisa Bodei,
    • and Mark Kidd

    A multianalyte PCR blood test outperforms single analyte ELISAs (chromogranin A, pancreastatin, neurokinin A) for neuroendocrine tumor detection

    Endocr Relat Cancer 21 (4) 615-628, doi:10.1530/ERC-14-0190
    • Thérèse Truong,
    • Benoît Liquet,
    • Florence Menegaux,
    • Sabine Plancoulaine,
    • Pierre Laurent-Puig,
    • Claire Mulot,
    • Emilie Cordina-Duverger,
    • Marie Sanchez,
    • Patrick Arveux,
    • Pierre Kerbrat,
    • Sylvia Richardson,
    • and Pascal Guénel

    Breast cancer risk, nightwork, and circadian clock gene polymorphisms

    Endocr Relat Cancer 21 (4) 629-638, doi:10.1530/ERC-14-0121 first published on 11 June 2014
    • Yunxin Liu,
    • Xianjun Fang,
    • Jie Yuan,
    • Zongxing Sun,
    • Chuanhua Li,
    • Rong Li,
    • Li Li,
    • Chao Zhu,
    • Rong Wan,
    • Rui Guo,
    • Lai Jin,
    • and Shengnan Li

    The role of corticotropin-releasing hormone receptor 1 in the development of colitis-associated cancer in mouse model

    Endocr Relat Cancer 21 (4) 639-651, doi:10.1530/ERC-14-0239
    • Thomas G Papathomas,
    • Lindsey Oudijk,
    • Ellen C Zwarthoff,
    • Edward Post,
    • Floor A Duijkers,
    • Max M van Noesel,
    • Leo J Hofland,
    • Patrick J Pollard,
    • Eamonn R Maher,
    • David F Restuccia,
    • Richard A Feelders,
    • Gaston J H Franssen,
    • Henri J Timmers,
    • Stefan Sleijfer,
    • Wouter W de Herder,
    • Ronald R de Krijger,
    • Winand N M Dinjens,
    • and Esther Korpershoek

    Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paraganglia

    Endocr Relat Cancer 21 (4) 653-661, doi:10.1530/ERC-13-0429 first published on 20 June 2014
    • Zaki Shaikhibrahim,
    • Anne Offermann,
    • Martin Braun,
    • Roopika Menon,
    • Isabella Syring,
    • Michael Nowak,
    • Rebecca Halbach,
    • Wenzel Vogel,
    • Christian Ruiz,
    • Tobias Zellweger,
    • Cyrill A Rentsch,
    • Maria Svensson,
    • Ove Andren,
    • Lukas Bubendorf,
    • Saskia Biskup,
    • Stefan Duensing,
    • Jutta Kirfel,
    • and Sven Perner

    MED12 overexpression is a frequent event in castration-resistant prostate cancer

    Endocr Relat Cancer 21 (4) 663-675, doi:10.1530/ERC-14-0171 first published on 17 June 2014
    • Teresa Elo,
    • Lan Yu,
    • Eeva Valve,
    • Sari Mäkelä,
    • and Pirkko Härkönen

    Deficiency of ERβ and prostate tumorigenesis in FGF8b transgenic mice

    Endocr Relat Cancer 21 (4) 677-690, doi:10.1530/ERC-13-0480 first published on 17 June 2014

Research Letter

    • Luke A Selth,
    • Matthew J Roberts,
    • Clement W K Chow,
    • Villis R Marshall,
    • Suhail A R Doi,
    • Andrew D Vincent,
    • Lisa M Butler,
    • Martin F Lavin,
    • Wayne D Tilley,
    • and Robert A Gardiner

    Human seminal fluid as a source of prostate cancer-specific microRNA biomarkers

    Endocr Relat Cancer 21 (4) L17-L21, doi:10.1530/ERC-14-0234 first published on 23 May 2014
|

This Issue

August 2014; 21 (4)
Cover
  1. Profile
  2. Editorial
  3. Thematic Reviews
  4. Commentary
  5. Reviews
  6. Research
  7. Research Letter

Find articles in this issue containing these words:

New Articles: issue in progress

  1. December 2017, 24 (12)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most